Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter B Simpson

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Cell Biochemistry and Biophysics|April 7, 2011
Enzymatic characterisation of USP7 deubiquitinating activity and inhibitionJonathan D Wrigley, Kay Eckersley, Ian M Hardern, et al.
Journal of Medicinal Chemistry|September 16, 2005
A new pyridazine series of GABAA alpha5 ligandsMonique B van Niel, Kevin Wilson, Charles H Adkins, et al.
Bioorganic & Medicinal Chemistry Letters|November 11, 2008
The discovery of AZD5597, a potent imidazole pyrimidine amide CDK inhibitor suitable for intravenous dosingClifford D Jones, David M Andrews, Andrew J Barker, et al.
Theranostics|October 12, 2020
Ultrasound-triggered therapeutic microbubbles enhance the efficacy of cytotoxic drugs by increasing circulation and tumor drug accumulation and limiting bioavailability and toxicity in normal tissuesNicola Ingram, Laura E McVeigh, Radwa H Abou-Saleh, et al.
Nature Reviews. Drug Discovery|December 15, 2021
IMI European Lead Factory - democratizing access to high-throughput screeningPhilip S Jones, Sylviane Boucharens, Stuart P McElroy, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Cell Biochemistry and Biophysics|April 7, 2011
Enzymatic characterisation of USP7 deubiquitinating activity and inhibitionJonathan D Wrigley, Kay Eckersley, Ian M Hardern, et al.
Journal of Medicinal Chemistry|September 16, 2005
A new pyridazine series of GABAA alpha5 ligandsMonique B van Niel, Kevin Wilson, Charles H Adkins, et al.
Bioorganic & Medicinal Chemistry Letters|November 11, 2008
The discovery of AZD5597, a potent imidazole pyrimidine amide CDK inhibitor suitable for intravenous dosingClifford D Jones, David M Andrews, Andrew J Barker, et al.
Theranostics|October 12, 2020
Ultrasound-triggered therapeutic microbubbles enhance the efficacy of cytotoxic drugs by increasing circulation and tumor drug accumulation and limiting bioavailability and toxicity in normal tissuesNicola Ingram, Laura E McVeigh, Radwa H Abou-Saleh, et al.
Nature Reviews. Drug Discovery|December 15, 2021
IMI European Lead Factory - democratizing access to high-throughput screeningPhilip S Jones, Sylviane Boucharens, Stuart P McElroy, et al.
Pageof 3